PMID- 20813958 OWN - NLM STAT- MEDLINE DCOM- 20101102 LR - 20211020 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 107 IP - 38 DP - 2010 Sep 21 TI - Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis. PG - 16524-9 LID - 10.1073/pnas.1002642107 [doi] AB - Ligand-driven dimerizations of ErbB receptor subunits fulfill a fundamental role in their activation. We have used the number and brightness analysis technique to investigate the existence of preformed ligand-independent dimers and clusters and to characterize the initial steps in the activation of ErbB1 and ErbB2. In cells expressing 50,000-200,000 receptors, ErbB1 was monomeric in the absence of ligand stimulation, whereas in CHO cells with receptor levels >500,000 as much as 30% of ErbB1 was present as preformed dimers. EGF induced the formation of ErbB1 dimers as well as larger clusters (up to pentamers) that colocalized with clathrin-coated pits. The distribution of unstimulated ErbB2 in cells expressing 3.10(5)-10(6) receptors was fundamentally different, in that this receptor was present in preformed homoassociated aggregates containing 5-10 molecules. These constitutive ErbB2 homoclusters colocalized with caveolae, increased in size at subphysiological temperatures, but decreased in size upon EGF stimulation. We conclude that these ErbB2 clusters are promoted primarily by membrane-mediated interactions and are dispersed upon ligand stimulation. FAU - Nagy, Peter AU - Nagy P AD - Laboratory of Cellular Dynamics, Max Planck Institute for Biophysical Chemistry, Am Fassberg 11, D-37077 Gottingen, Germany. FAU - Claus, Jeroen AU - Claus J FAU - Jovin, Thomas M AU - Jovin TM FAU - Arndt-Jovin, Donna J AU - Arndt-Jovin DJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100902 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Ligands) RN - 0 (Luminescent Proteins) RN - 0 (Recombinant Fusion Proteins) RN - 0 (enhanced green fluorescent protein) RN - 147336-22-9 (Green Fluorescent Proteins) RN - 62229-50-9 (Epidermal Growth Factor) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 2.7.10.1 (Receptor, ErbB-2) SB - IM MH - Animals MH - Base Sequence MH - CHO Cells MH - Cricetinae MH - Cricetulus MH - Epidermal Growth Factor/pharmacology MH - ErbB Receptors/chemistry/genetics/*metabolism MH - Green Fluorescent Proteins/chemistry/genetics/metabolism MH - HeLa Cells MH - Humans MH - Ligands MH - Luminescent Proteins/chemistry/genetics/metabolism MH - Mice MH - Microscopy, Fluorescence MH - Plasmids/genetics MH - Protein Multimerization/drug effects MH - Protein Structure, Quaternary/drug effects MH - Receptor, ErbB-2/chemistry/genetics/*metabolism MH - Recombinant Fusion Proteins/chemistry/genetics/metabolism MH - Signal Transduction MH - Transfection PMC - PMC2944731 COIS- The authors declare no conflict of interest. EDAT- 2010/09/04 06:00 MHDA- 2010/11/03 06:00 PMCR- 2010/09/02 CRDT- 2010/09/04 06:00 PHST- 2010/09/04 06:00 [entrez] PHST- 2010/09/04 06:00 [pubmed] PHST- 2010/11/03 06:00 [medline] PHST- 2010/09/02 00:00 [pmc-release] AID - 1002642107 [pii] AID - 201002642 [pii] AID - 10.1073/pnas.1002642107 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16524-9. doi: 10.1073/pnas.1002642107. Epub 2010 Sep 2.